Skip to content

Lavender Aromatherapy in the Treatment of Anxiety And Dpression

Comparative Effectiveness of Lavender and Almond oil odor aroma therapy On Anxiety and Depression Patients Admitted to the cardiac intensive care unit

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012111711498N1
Enrollment
110
Registered
2014-06-04
Start date
2012-12-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ANXEITY AND DEORESION. Neurotic, stress-related and somatoform disorders

Interventions

Intervention 1: Groups: first test: questions HADS (half hour before intervention) starting around 11 am instill 2 drops essential oil of Lavender by interfering emitters connected to a collar on pape
Treatment - Drugs
Placebo
Groups: first test: questions HADS (half hour before intervention) starting around 11 am instill 2 drops essential oil of Lavender by interfering emitters connected to a collar on paper and asking the
Groups:placebo test: questions HADS (half hour before intervention) starting around 11 am instill 2 drops essential oil of Lavender by interfering emitters connected to a collar on paper and asking th

Sponsors

Shahed Univer Sity
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria:Having high anxiety and depression scores of 7 tools HADS,Age over 18 years , Patients with a diagnosis of ischemic heart disease, angina and myocardial infarction,No risk of cardiogenic shock, having very poor medical condition, according to doctors at the hospital, Agree attract physicians to enter patients into the study, no pacemaker, no use of complementary therapies (herbal treatments, traditional and other therapies) in a week, no history of psychiatric disorders or being treated for anxiety and depression, lack of drug abuse, no history of asthma, eczema. Exclusion criteria included: patient withdrew from the study, grade 3 or 4 heart failure, discharge, or transfer the patient died before the completion of the study, a new stressful situations

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Anxiety. Timepoint: Before the experiment, a time period of 2 days, 9 hours after the intervention. Method of measurement: HADS, Hospital Anxiety and Depression questionnaire.;DEPRESSION. Timepoint: Before the experiment, a time period of 2 days, 9 hours after the intervention. Method of measurement: HADS, Hospital Anxiety and Depression questionnaire.

Secondary

MeasureTime frame
Blood pressure. Timepoint: Before the study, an hour later, 9 hours after the study. Method of measurement: Each patient monitoring devices over.;PULSE. Timepoint: Before the study, an hour later, 9 hours after the study. Method of measurement: Each patient monitoring devices over.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Reza Heydari

Shahed University

HEIDARI43@YAHOO.COM+216 6418590

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026